CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for CK Life Sciences Intl (Holdings) Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

CK Life Sciences Intl (Holdings) Inc
2 Dai Fu Street
Tai Po Industrial Estate
Phone: +852 21261212p:+852 21261212 Hong Kong Ticker: 775775

Business Summary
CK Life Sciences Intl (Holdings) Inc is an investment holding company principally engaged in the development and sales of healthcare products. The Company operates through two segments. The Health segment is engaged in the development, production, marketing and sales of healthcare and pharmaceutical products. The healthcare brands under the Company include Lipa, Vitaquest and Sante Naturelle, among others. Its pharmaceutical products include cancer-related pharmaceuticals and painkillers, among others. The Agriculture-related Businesses segment is engaged in the operation of vineyards, as well as the development, production, marketing and sales of agriculture and related products. Its agricultural products include fertilizers and crop protection products, among others.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board Tzar KuoiLi 59 4/1/2002 4/1/2002
President, Executive Director Hing LamKam 76 9/1/2020 6/1/2002
Chief Executive Officer, Compliance Officer, Vice President, Executive Director Ying ChoiYu 66 9/1/2020
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Wex Pharmaceuticals Inc. Suite 1601 - 700 West Pender Street Vancouver BC Canada
VitaQuest International LLC 6 Henderson Drive West Caldwell NJ United States
Lipa Pharmaceuticals Limited 21 Reaghs Farm Road Minto NSW Australia
Challenger Wine Trust Level 15, 255 Pitt Street Sydney NSW Australia

Business Names
Business Name
¦¤ Belvino Investments Trust
0775
775
45 additional Business Names available in full report.

General Information
Number of Employees: 1,932 (As of 12/31/2023)
Outstanding Shares: 9,611,073,000 (As of 12/31/2023)
Stock Exchange: HKG
Fax Number: +852 21261211


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024